Xinyi Du

620 total citations · 1 hit paper
24 papers, 416 citations indexed

About

Xinyi Du is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xinyi Du has authored 24 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Xinyi Du's work include MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (3 papers) and Big Data and Business Intelligence (2 papers). Xinyi Du is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (3 papers) and Big Data and Business Intelligence (2 papers). Xinyi Du collaborates with scholars based in China, United Kingdom and Netherlands. Xinyi Du's co-authors include Kangqi Jiang, Zhongfei Chen, Chenlin Gao, Qing‐Qing Tan, Yong Xu, Chengyu Jiang, Lei Fan, Song Mei, Huayuan Zhu and Yiming Ma and has published in prestigious journals such as Blood, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xinyi Du

19 papers receiving 407 citations

Hit Papers

Firms' digitalization and stock price crash risk 2022 2026 2023 2024 2022 50 100 150 200

Peers

Xinyi Du
Chengbo Fu Canada
A. Mina United Kingdom
Yumei Fu China
Jing Jia Australia
Xiaoni Li Spain
Chengbo Fu Canada
Xinyi Du
Citations per year, relative to Xinyi Du Xinyi Du (= 1×) peers Chengbo Fu

Countries citing papers authored by Xinyi Du

Since Specialization
Citations

This map shows the geographic impact of Xinyi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Du more than expected).

Fields of papers citing papers by Xinyi Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Du. The network helps show where Xinyi Du may publish in the future.

Co-authorship network of co-authors of Xinyi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Du. A scholar is included among the top collaborators of Xinyi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Du. Xinyi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Mengling & Xinyi Du. (2025). Digital government and air pollution inequality: Evidence from Chinese cities. Economic Modelling. 152. 107301–107301. 1 indexed citations
2.
Lu, Yingying, et al.. (2025). Toxic metals and trace elements, markers of inflammation, and hyperandrogenemia in women and testosterone deficiency in men: Associations and potential mediating factors. Ecotoxicology and Environmental Safety. 299. 118352–118352. 1 indexed citations
3.
Zheng, Xiaoming, Xinyi Du, & Weihao Wu. (2025). The impact of digital government on cross-regional investment: Evidence from Chinese cities. Economic Analysis and Policy. 87. 99–122. 2 indexed citations
4.
Jiang, Kangqi, et al.. (2025). The risk effects of corporate digitalization: exacerbate or mitigate?. Humanities and Social Sciences Communications. 12(1). 2 indexed citations
5.
Meng, Lingjie, Anli Liu, Qian Cao, et al.. (2025). Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice. Frontiers in Pharmacology. 16. 1577201–1577201.
6.
Xiao, Chunjing, Xue Jiang, Xinyi Du, et al.. (2024). Boundary-enhanced time series data imputation with long-term dependency diffusion models. Knowledge-Based Systems. 310. 112917–112917. 5 indexed citations
8.
Wang, Xiaona, Yu Zhao, Xiaobei Li, et al.. (2023). Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice. Science China Life Sciences. 66(10). 2370–2379. 4 indexed citations
9.
Du, Xinyi & Kangqi Jiang. (2022). Promoting enterprise productivity: The role of digital transformation. Borsa Istanbul Review. 22(6). 1165–1181. 88 indexed citations
10.
Liu, Hailing, Lei Cao, Yi Miao, et al.. (2022). Effects of conventional interventions on early-stage primary cutaneous marginal zone lymphoma: A population-based study. Leukemia Research. 114. 106795–106795.
11.
Jiang, Kangqi, Xinyi Du, & Zhongfei Chen. (2022). Firms' digitalization and stock price crash risk. International Review of Financial Analysis. 82. 102196–102196. 230 indexed citations breakdown →
12.
Du, Xinyi, Hailing Liu, Changqing Yang, et al.. (2021). LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia. Leukemia Research. 110. 106706–106706. 10 indexed citations
13.
Ma, Yiming, Xinyi Du, Dandan Zhao, et al.. (2021). 18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice. Biochemical and Biophysical Research Communications. 579. 168–174. 11 indexed citations
14.
Tan, Qing‐Qing, Xinyi Du, Chenlin Gao, & Yong Xu. (2021). Higher Dietary Inflammatory Index Scores Increase the Risk of Diabetes Mellitus: A Meta-Analysis and Systematic Review. Frontiers in Endocrinology. 12. 693144–693144. 21 indexed citations
16.
Liu, Yun, Yi Miao, Xinyi Du, et al.. (2020). A feedback circuit of miR-34a/MDM4/p53 regulates apoptosis in chronic lymphocytic leukemia cells. Translational Cancer Research. 9(10). 6143–6153. 6 indexed citations
17.
Cao, Lei, Fei Wang, Xinyi Du, et al.. (2020). Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies. Scientific Reports. 10(1). 16357–16357. 8 indexed citations
18.
Fan, Lei, Chao Wang, Zhiqiang Wang, et al.. (2019). SHC014748M, a Novel Selective Inhibitor of PI3Kδ, Demonstrates Promising Pre-Clinical Antitumor Activity in B Cell Lymphomas and CLL. Blood. 134(Supplement_1). 5306–5306. 1 indexed citations
19.
He, Changsheng, Xinyi Du, Hai‐jie Wang, et al.. (2018). Advancing the predictivity of skin sensitization by applying a novel HMOX1 reporter system. Archives of Toxicology. 92(10). 3103–3115. 7 indexed citations
20.
Hou, Junqing, Zhenhua Zhao, Tie‐Qiang Li, et al.. (2017). Expression of speckle-type poxvirus and zinc finger protein in prostate cancer. Zhonghua shiyan waike zazhi. 34(3). 509–511. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026